Skip to main content
logo
ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.290
-0.040 (-3.01%)
Nov 6, 2026, 4:13 AM EST - Market open

ProQR Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
182213273161264570
Market Cap Growth
-27.39%-22.19%70.19%-39.20%-53.63%170.61%
Enterprise Value
6610719356187430
Last Close Price
1.332.022.651.983.708.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.9211.0913.5222.0556.74210.75
PB Ratio
2.073.672.983.513.714.43
P/TBV Ratio
2.073.672.983.513.694.40
P/FCF Ratio
---7.21--
P/OCF Ratio
---6.75--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.395.569.557.6340.19158.93
EV/FCF Ratio
---2.49--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.190.320.190.480.330.53
Debt / FCF Ratio
---0.98--
Net Debt / Equity Ratio
-1.28-1.55-1.49-2.40-1.09-1.12
Net Debt / EBITDA Ratio
2.431.804.472.911.132.25
Net Debt / FCF Ratio
2.031.423.50-4.921.054.80
Asset Turnover
0.140.120.130.040.020.02
Quick Ratio
3.413.013.893.517.246.83
Current Ratio
3.493.093.963.547.366.94
Return on Equity (ROE)
-57.40%-61.17%-42.73%-51.33%-71.37%-71.62%
Return on Assets (ROA)
-19.76%-19.35%-12.45%-14.06%-21.38%-23.20%
Return on Capital Employed (ROCE)
-43.40%-54.10%-23.60%-33.60%-43.30%-31.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-35.49%-23.28%-10.51%-19.34%-26.05%-12.12%
FCF Yield
-29.87%-29.69%-14.31%13.88%-27.99%-5.29%
Buyback Yield / Dilution
-8.75%-22.36%-6.26%-13.08%-11.62%-28.21%
SEC Filings: 10-K · 10-Q